###begin article-title 0
###xml 54 59 <span type="species:ncbi:9606">human</span>
Impact of gene variants on sex-specific regulation of human Scavenger receptor class B type 1 (SR-BI) expression in liver and association with lipid levels in a population-based study
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 52 58 52 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
Several studies have noted that genetic variants of SCARB1, a lipoprotein receptor involved in reverse cholesterol transport, are associated with serum lipid levels in a sex-dependent fashion. However, the mechanism underlying this gene by sex interaction has not been explored.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 117 124 117 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 176 183 176 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 403 410 403 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 291 296 <span type="species:ncbi:9606">women</span>
###xml 461 466 <span type="species:ncbi:9606">human</span>
We utilized both epidemiological and molecular methods to study how estrogen and gene variants interact to influence SCARB1 expression and lipid levels. Interaction between 35 SCARB1 haplotype-tagged polymorphisms and endogenous estradiol levels was assessed in 498 postmenopausal Caucasian women from the population-based Rancho Bernardo Study. We further examined associated variants with overall and SCARB1 splice variant (SR-BI and SR-BII) expression in 91 human liver tissues using quantitative real-time PCR.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 73 80 73 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 220 222 220 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-4</sup>
###xml 255 257 255 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-3</sup>
###xml 315 317 315 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-4</sup>
###xml 490 495 <span type="species:ncbi:9606">women</span>
Several variants on a haplotype block spanning intron 11 to intron 12 of SCARB1 showed significant gene by estradiol interaction affecting serum lipid levels, the strongest for rs838895 with HDL-cholesterol (p = 9.2 x 10-4) and triglycerides (p = 1.3 x 10-3) and the triglyceride:HDL cholesterol ratio (p = 2.7 x 10-4). These same variants were associated with expression of the SR-BI isoform in a sex-specific fashion, with the strongest association found among liver tissue from 52 young women <45 years old (p = 0.002).
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
###xml 13 20 13 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 79 86 79 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
Estrogen and SCARB1 genotype may act synergistically to regulate expression of SCARB1 isoforms and impact serum levels of HDL cholesterol and triglycerides. This work highlights the importance of considering sex-dependent effects of gene variants on serum lipid levels.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 201 202 201 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 203 204 203 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 423 424 423 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 425 426 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 468 469 468 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 470 471 470 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 585 586 585 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 736 737 736 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 789 795 789 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 1169 1170 1169 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 1309 1311 1309 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 567 584 <span type="species:ncbi:11103">hepatitis C virus</span>
###xml 1025 1030 <span type="species:ncbi:10090">mouse</span>
###xml 1035 1038 <span type="species:ncbi:10116">rat</span>
###xml 1224 1229 <span type="species:ncbi:9606">human</span>
The scavenger receptor class B type 1 (SR-BI) is a plasma membrane protein that binds high density lipoprotein (HDL) with high affinity and mediates selective uptake of cholesterol esters by the liver[1,2]. Besides its role as a functional HDL receptor involved in reverse cholesterol transport, SR-BI also participates in the metabolism of Apolipoprotein B-containing lipoproteins, including low density lipoprotein (LDL)[3,4] and very low density lipoprotein (VLDL)[5,6]. In addition, studies have implicated SR-BI as a key co-receptor mediating infection with the hepatitis C virus[7], where chronic infection is characterized by marked lipid changes reflecting viral dependence on host lipid metabolism for replication and assembly[8]. The full length gene encoding SR-BI (gene symbol SCARB1) is comprised of 13 exons that are alternatively spliced to produce two major transcripts: the full length SR-BI and the splice variant SR-BII, in which exon 12 is skipped. SR-BI and SR-BII splice forms are conserved in both the mouse and rat genomes, have different tissue distributions and may influence cellular cholesterol trafficking and homeostasis in different ways[9]. SR-BII is reported to be a minor splice variant in human liver and has been shown to be less efficient at reverse cholesterol transport[10].
###end p 10
###begin p 11
###xml 119 126 119 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 310 317 310 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 392 394 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 589 591 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 592 594 592 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 598 600 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 3 9 <span type="species:ncbi:9606">humans</span>
###xml 521 524 <span type="species:ncbi:9606">men</span>
###xml 529 534 <span type="species:ncbi:9606">women</span>
In humans, with the exception of genome-wide association studies, targeted investigations into the association between SCARB1 single nucleotide polymorphisms (SNPs) and serum lipids have been limited to a handful of polymorphisms in either exon 1, intron 5 or exon 8. These studies have found polymorphisms of SCARB1 associated with serum levels of triglycerides [11-14], HDL cholesterol [11-18], LDL cholesterol[11,12,17] and VLDL[12]. Interestingly, many of these studies show different effects of the polymorphisms in men and women, suggesting a possible mediating role of sex hormones[11-15,17,18].
###end p 11
###begin p 12
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 246 252 246 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 492 494 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 495 497 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 667 669 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 147 152 <span type="species:ncbi:9606">women</span>
###xml 524 529 <span type="species:ncbi:9606">human</span>
Estrogen is known to have a profound impact on serum lipid levels, resulting in a decrease in LDL cholesterol and triglycerides, affording younger women relative protection from coronary artery disease[19]. Estrogen is also a potent regulator of SCARB1, influencing the relative expression of SR-BI and SR-BII isoforms[20]. In rodent models, treatment with high doses of estrogen suppressed liver expression of full length SR-BI isoform, but increased expression of the splice variant SR-BII[21,26]. Similarly, treatment of human HepG2 liver cell lines with estradiol has been shown to result in a down-regulation of SR-BI and up-regulation of the SR-BII splice form[24,27].
###end p 12
###begin p 13
###xml 52 59 52 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 293 300 293 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 408 415 408 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 638 645 638 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 690 697 690 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 787 794 787 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 155 160 <span type="species:ncbi:9606">women</span>
###xml 478 483 <span type="species:ncbi:9606">women</span>
###xml 540 545 <span type="species:ncbi:9606">women</span>
###xml 718 723 <span type="species:ncbi:9606">human</span>
###xml 882 887 <span type="species:ncbi:9606">human</span>
We previously described how the association between SCARB1 gene variants and HDL cholesterol levels varied by estrogen therapy status among postmenopausal women from the community-based Rancho Bernardo Study [28]. In the current study, we took a comprehensive SNP tagging approach to identify SCARB1 genetic variation influencing lipid levels in an estrogen dependent manner. We examined interaction between SCARB1 genotypes and endogenous estradiol levels among postmenopausal women, where levels of estradiol are lower than premenopausal women but not subject to monthly fluctuations. We further explored the functional consequences of SCARB1 genetic variation on alternative splicing of SCARB1 in a large series of human liver tissues. We report here how both endogenous estrogen and SCARB1 genotype synergistically influence serum levels of HDL cholesterol and triglycerides in human populations and how this effect may be mediated through expression of the SR-BI isoform.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Rancho Bernardo Study
###end title 15
###begin p 16
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1294 1296 1294 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1633 1635 1633 1635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 64 67 <span type="species:ncbi:9606">men</span>
###xml 72 77 <span type="species:ncbi:9606">women</span>
###xml 363 368 <span type="species:ncbi:9606">women</span>
###xml 568 573 <span type="species:ncbi:9606">women</span>
###xml 651 656 <span type="species:ncbi:9606">women</span>
###xml 1521 1526 <span type="species:ncbi:9606">women</span>
###xml 2289 2294 <span type="species:ncbi:9606">women</span>
###xml 2438 2443 <span type="species:ncbi:9606">women</span>
###xml 2498 2503 <span type="species:ncbi:9606">women</span>
The Rancho Bernardo Study is a population-based cohort of white men and women, established during 1972-1974 in the suburban community of Rancho Bernardo, California[29]. The present study utilizes medical history, current medication use and health behaviors assessed from standardized questionnaires, anthropometric measures, and laboratory measures collected on women between 1984 and 1987 during a follow-up visit focusing on diabetes and cardiovascular disease (visit 4). At the time of this visit, the average age of subjects was 70 years and the vast majority of women were postmenopausal. Therefore, we restricted our analyses to postmenopausal women. Subjects who participated in this visit provided morning blood samples obtained after an overnight fast and used to measure lipid and lipoprotein levels. Fasting serum cholesterol, triglyceride and HDL cholesterol levels were measured in a Center for Disease Control-Certified Lipid Research Clinic laboratory. Total cholesterol and triglyceride levels were measured by enzymatic techniques using an ABA-200 biochromatic analyzer (Abbott Laboratories, Irving, TX). HDL cholesterol was measured after precipitation of the other lipoproteins with heparin and manganese chloride. LDL cholesterol was estimated using the Friedewald formula[30]. Current use of estrogen therapy was validated by examination of pills or prescriptions brought to the clinic for that purpose and was classified as current versus non-current use. Endogenous estradiol in non-hormone using women was measured between 1992 and 1993 by radioimmunoassay after solvent extraction and column-chromatography[31] using first-thawed fasting morning specimens from the 1984-1987 venipuncture. Measurements were performed in the endocrinology research laboratory of S. S. C. Yen (Department of Reproductive Medicine, University of California-San Diego, La Jolla, CA). Serum estradiol is stable for >10 years when kept frozen at -70C (personal communication from S. Yen). The sensitivity and the intra- and inter-assay coefficients of variation, respectively, were 11 pmol/L, 5.9% and 7.1%. Because of a skewed distribution, estradiol measures were grouped into tertiles with the following cutoffs: low (7-17 pmol/L); medium (18-24 pmol/L); high (25-58 pmol/L). The 52 women with estradiol levels below the lower limit of detection (representing about 10% of the cohort) were included in the low estradiol group. Five women with estradiol levels above normal for postmenopausal women (>217 pmol/L) were excluded.
###end p 16
###begin p 17
###xml 127 134 127 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 320 327 320 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 419 420 419 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 452 453 452 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 539 546 539 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 42 47 <span type="species:ncbi:9606">women</span>
###xml 467 472 <span type="species:ncbi:9606">women</span>
###xml 576 581 <span type="species:ncbi:9606">women</span>
###xml 629 634 <span type="species:ncbi:9606">women</span>
###xml 670 675 <span type="species:ncbi:9606">women</span>
###xml 786 791 <span type="species:ncbi:9606">women</span>
There were a total of 899 post-menopausal women who participated in visit 4 and provided a blood sample for DNA. There were 83 SCARB1 SNPs with minor allele frequency >0.05 in Caucasians in the HapMap database. The Tagger program in Haploview software version 3.2 [32] was used to select 35 haplotype tagged SNPs in the SCARB1 gene having minor allele frequencies of >0.05 and capturing all alleles with correlations (r2) >0.80 among Caucasians (Table 1). Of the 899 women with blood samples available, 793 were successfully genotyped for SCARB1 SNPs. We further excluded six women missing primary lipid data; an additional nine women on lipid lowering therapy; and 280 women currently taking estrogen therapy on whom estradiol measures were not measured, leaving a final sample of 498 women.
###end p 17
###begin p 18
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
SCARB1 SNPs evaluated in the Rancho Bernardo Study.
###end p 18
###begin p 19
*Proxy SNP for exon 8 SNP evaluated in previous studies (rs5888)
###end p 19
###begin title 20
Liver Samples
###end title 20
###begin p 21
###xml 336 337 336 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 115 120 <span type="species:ncbi:9606">Child</span>
###xml 132 137 <span type="species:ncbi:9606">Human</span>
###xml 343 348 <span type="species:ncbi:9606">human</span>
Post-mortum liver tissues from 93 otherwise healthy Caucasian adults were purchased from the National Institute of Child Health and Human Development Brain and Tissue Bank for Developmental Disorders (University of Maryland, Baltimore, MD). All had a post mortem interval (PMI) <24 hours. A demographic description is included in Table 2. The human hepatoma (HepG2) cell line was obtained from American Type Culture Collection (Manassas, VA).
###end p 21
###begin p 22
###xml 32 39 32 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
Demographic characteristics and SCARB1 SNP minor allele carrier frequencies in 93 post-mortem liver samples, obtained from otherwise healthy Caucasian adults.
###end p 22
###begin p 23
PMI = post mortem interval. Age and PMI are presented as means +/- standard deviation.
###end p 23
###begin title 24
RNA extraction and cDNA synthesis from liver tissue
###end title 24
###begin p 25
Total RNA was extracted from liver sample (100 mg) using TRIzol reagent (Invitrogen, Carlsbad, CA) followed by purification with RNeasy kit using an on-column DNase treatment (Qiagen, Inc., Valencia, CA) following the manufacturer's protocol. RNA concentration was determined spectrophotometrically at 260 nm, while the quality of the purification was determined by 260 nm/280 nm ratio. Additionally, quality of sample and lack of significant degradation products was confirmed on an Agilent Bioanalyzer. Next, cDNA was synthesized using MultiScribe RT enzyme (Applied Biosystems, Foster City, CA) under the following conditions: 10 min at 25degreesC and 120 min at 37degreesC.
###end p 25
###begin title 26
Real time PCR
###end title 26
###begin p 27
###xml 41 48 41 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 103 109 103 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 351 357 351 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(PPIA)</italic>
###xml 519 521 519 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 958 964 934 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 992 999 968 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 1393 1398 1369 1374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA </italic>
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 318 323 <span type="species:ncbi:9606">human</span>
###xml 439 444 <span type="species:ncbi:10090">mouse</span>
Real-time PCR was used to quantify human SCARB1 mRNA levels (SR-BI isoform, SR-BII isoform and overall SCARB1) using commercially available TaqMan assays. Briefly, each liver sample was assayed by quantitative real-time PCR using the ABI 7900 to determine the level of the target message relative to mRNA encoding the human peptidylprolyl isomerase A (PPIA). This housekeeping gene has been shown to be among the most stable in studies of mouse liver, making it ideal for normalization in liver gene expression studies[33]. Each cDNA (50 ng) was amplified in duplicate using TaqMan Gene Expression PCR master mix reagent (Applied Biosystems, Foster City, CA) under the following conditions: 2 min at 50degreesC, 10 min at 95degreesC, 40 cycles: 15 sec at 95degreesC, and 1 min at 60degreesC. The different target cDNAs were amplified using the following ABI MGB probe and primer set assays (Applied Biosystems, Foster City, CA): ID HS00969822_m1 for overall SCARB1, targeting the junction of SCARB1 exon 2-3 which is conserved across all isoforms; HS00969819_m1 for SR-BI (includes exon 12), targeting the junction of exons 11-12; and a custom assay designed for SR-BII (excludes exon 12), with forward primer 5'TCCCTGTCATCTGCCAAATCC-3', reverse primer 5'-GGCTGGCTCACGGTGT-3' and probe 5'-CCTCAGGACCTTGGCTCC-3' targeting the junction of exons 11-13. All three mRNA assays were normalized to a PPIA mRNA control (ABI MGB probe and primer set assay ID Hs99999904_m1).
###end p 27
###begin p 28
###xml 268 281 260 265 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-&#916;&#916;Ct</sup>
###xml 297 303 277 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">target</italic>
###xml 309 313 289 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 389 395 353 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
The data were analyzed using the DeltaDeltaCt method, with a threshold set in the linear range of amplification. The cycle number at which any particular sample crossed that threshold (Ct) was then used to determine fold difference. Fold difference was calculated as 2-DeltaDeltaCt; DeltaCt = [Ct(target)-Ct (PPIA)]. DeltaDeltaCt = [DeltaCt(sample)]-[DeltaCt(calibrator)], where target is SCARB1, SR-BI or SR-BII. The calibrator was a single, randomly selected control liver sample used in each plate for normalization within and across runs and used in creation of standard curves. Each sample was run in duplicate in two independent plates, over all 4 repeats. The DeltaDeltaCt results obtained with the four repeats were average to determine the fold expression level used in the association analysis.
###end p 28
###begin p 29
###xml 502 508 502 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 530 534 530 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 598 603 598 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA </italic>
###xml 737 738 737 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
###xml 330 335 <span type="species:ncbi:9606">human</span>
We controlled for DNA contamination by running three randomly selected, RNA control samples that were not converted to cDNA and no-cDNA/RNA sample in each plate. No observable amplification was detected. In addition for assay validation we generated standard curves for each target and reference assay, using different amounts of human liver total RNA (1-1000 ng). In addition, the slope of the relative efficiency plot for each target and internal control were determined to validate the assays, i.e. SCARB1, SR-BI or SR-BII and PPIA. The slope in the relative efficiency plot for each target and PPIA were determined, and showed a standard value (<0.1) required for the validation of the relative quantitative method. (Additional file 1, Figure S1).
###end p 29
###begin title 30
SCARB1 genotyping
###end title 30
###begin p 31
###xml 98 105 98 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 458 460 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 564 566 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
Genomic DNA was isolated using conventional protocol by Qiagen kits (Qiagen, Inc., Valencia, CA). SCARB1 genotypes were assayed in genomic DNA isolated from frozen whole blood samples from subjects in the Rancho Bernardo Study and from the liver tissues and HepG2 cell line using either the Sequenom iPLEXtrade mark multiplex mass spectrometry genotyping system (Sequenom, Inc, La Jolla, CA) or using the 5' nuclease assay with allele specific TaqMan probes[34]. The percent missing genotypes and Hardy-Weinberg Equilibrium were evaluated using Haploview software[32] as a means of quality control.
###end p 31
###begin title 32
Statistical analysis
###end title 32
###begin p 33
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 204 211 204 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
SAS statistical software, Version 9.1 (SAS Institutes, Cary, NC) was used for all statistical analyses. The ggplot2 package[35] of the R language was also used for plots[36]. The association between each SCARB1 SNP and levels of total cholesterol, LDL cholesterol, triglycerides, HDL cholesterol and the triglyceride:HDL cholesterol ratio in the Rancho Bernardo Study was assessed with Analysis of Variance (ANOVA). Triglycerides, HDL cholesterol, LDL cholesterol, and the TG/HDL cholesterol ratio were natural log (ln) transformed to improve normality of the residuals. SNP genotypes were coded in an additive model, except for SNPs where the minor allele frequency was below 5%, in which case heterozygous and homozygous variant genotypes were pooled to test a dominant model. All models controlled for age (continuous) and current estrogen therapy status. Interactions between SNPs and estradiol levels (based on tertile cutoffs) were determined by introduction of a cross-product term in the model.
###end p 33
###begin p 34
###xml 23 29 23 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 124 131 124 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 567 574 567 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 658 665 650 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1)</italic>
Differences in overall SCARB1, SR-BI and SR-BII expression in liver samples were examined by sex and by presence/absence of SCARB1 allelic variants using standard linear regression analysis, controlling for post-mortum interval and age. Genotypes were coded in a dominant model (homozygous variant and heterozygote genotypes pooled) because of small numbers. Genotype by sex interaction was determined by inclusion of a cross product term in the model. Expression levels were natural log (ln) transformed for analysis. The proportion of SR-BI and SR-BII out of total SCARB1 was determined by calculating the DeltaDeltact ratios (i.e. SR-BI or SR-BII/overall SCARB1).
###end p 34
###begin p 35
This study was approved by the Institutional Review Boards at Duke University.
###end p 35
###begin title 36
Results
###end title 36
###begin title 37
###xml 43 48 <span type="species:ncbi:9606">women</span>
Genotype associations with lipid traits in women from the Rancho Bernardo Study
###end title 37
###begin p 38
###xml 33 40 33 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 220 221 220 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 299 300 299 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 341 348 341 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 951 957 951 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 1076 1077 1076 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 1087 1088 1087 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 1505 1506 1505 1506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 1696 1703 1696 1703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 243 248 <span type="species:ncbi:9606">women</span>
###xml 499 504 <span type="species:ncbi:9606">women</span>
Minor allele frequencies for the SCARB1 SNPs typed in this study ranged from 0.04 to 0.44. The average call rate was 97% and one SNP had nominally significant (p < 0.006) deviation from Hardy-Weinberg equilibrium (Table 1). Characteristics of women from the Rancho Bernardo Study are shown in Table 3. We modeled the interaction between the SCARB1 SNPs and estradiol levels on serum total cholesterol, triglycerides, HDL cholesterol, LDL cholesterol and the triglyceride:HDL cholesterol ratio among women not currently taking estrogen therapy. Two SNPs on the same haplotype block showed significant evidence of genotype by estradiol interaction (p < 0.05). The tag SNP rs838893 showed the strongest evidence of interaction for HDL cholesterol (p = 0.006), triglycerides (p = 0.001) and the triglyceride:HDL cholesterol ratio (p = 0.0005). This common variant (minor allele frequency 0.31) lies on a haplotype block spanning intron 11 to intron 12 of SCARB1. We examined additional SNPs on this block, all of which showed a similar pattern of significant associations (Figure 1). Figure 2 illustrates how at low levels of estradiol, the variant allele, G', of the most significant of these SNPs, rs838895, was associated with lower levels of triglycerides and high levels of HDL cholesterol, but at increasing levels of estradiol, the opposite was found. Importantly, this SNP showed no association with estradiol levels (p = 0.40). Results for another significant SNP, rs838896, are also shown in Figure 2 for comparison with results from the livers, presented below. Similar trends were seen for all assayed SNPs on that haplotype block. No significant interaction was found between any of the SCARB1 tagging SNPs and current use of estrogen therapy for HDL-C (p = 0.34) or triglycerides (p = 0.53).
###end p 38
###begin p 39
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 0 97 0 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>SCARB1 </italic>SNPs associated with lipid levels in an estradiol-dependent manner in postmenopausal women</bold>
###xml 136 143 136 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 223 230 223 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 398 400 398 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 92 97 <span type="species:ncbi:9606">women</span>
SCARB1 SNPs associated with lipid levels in an estradiol-dependent manner in postmenopausal women. Top panel - Intron/exon structure of SCARB1 isoforms, SR-BI and SR-BII; Middle two panels - P value for interaction between SCARB1 SNPs and endogenous estradiol levels for serum lipid levels in the Rancho Bernardo Study; Bottom panel - haplotype block representing associated interval (numbers are r2 values measuring pairwise linkage disequilibrium between SNPs). SNPs are ordered based on their position in the gene and from left (3') to right (5') ends of the gene. TC = total cholesterol; LDL-C = low density lipoprotein cholesterol; HDL-C = high density lipoprotein cholesterol; Trig = triglycerides; TGHDL = triglyceride:HDL-C ratio.
###end p 39
###begin p 40
###xml 10 17 10 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 0 82 0 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Effect of <italic>SCARB1 </italic>genotype on serum lipid levels by tertile of endogenous estradiol</bold>
Effect of SCARB1 genotype on serum lipid levels by tertile of endogenous estradiol. Shown are mean values of HDL cholesterol and triglycerides with 95% confidence intervals for subjects with 0, 1 or 2 copies of the rs838895 (panels A and B) and rs838896 (panels C and D) minor alleles. Endogenous estradiol tertiles were: low (7-17 pmol/L); medium (18-24 pmol/L); high (25-58 pmol/L).
###end p 40
###begin p 41
###xml 53 58 <span type="species:ncbi:9606">women</span>
Baseline characteristics of postmenopausal Caucasian women from the Rancho Bernardo Study in the overall cohort and by low, moderate or high estradiol (E2) tertile in the subset with estradiol measures available.
###end p 41
###begin p 42
* Median and interquartile range
###end p 42
###begin title 43
Expression levels and presence of alternative splice variants in liver tissue
###end title 43
###begin p 44
###xml 51 58 51 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 349 356 349 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 562 569 562 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 658 665 654 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 383 388 <span type="species:ncbi:9606">human</span>
Given the existence of alternative splice forms of SCARB1 involving inclusion/exclusion of exon 12, we hypothesized that a SNP located within the associated haplotype block may modulate splicing efficiency. We quantified the amounts of the full-length SR-BI isoform (including exon 12), the alternative SR-BII isoform (exon 12 skipping) and overall SCARB1 mRNA (all splice forms) in human liver tissues from 93 healthy individuals. SR-BI showed higher expression levels than SR-BII, consistent with other studies, but accounted for less than half of the overall SCARB1 expression: on average SR-BI accounted for 39 +/- 19% and SR-BII 3.5 +/- 1.8% of overall SCARB1 expression.
###end p 44
###begin title 45
###xml 68 73 <span type="species:ncbi:9606">human</span>
The effect of sex and genotype on alternative splicing of SCARB1 in human liver tissues
###end title 45
###begin p 46
###xml 53 60 53 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 151 157 151 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 275 281 275 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 731 738 731 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 862 869 862 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
In order to determine the functional consequences of SCARB1 SNPs, we carried out genetic association analysis of the associated SNPs and expression of SCARB1. We genotyped seven SNPs, including six within the associated haplotype block, which spans intron 11 to intron 12 of SCARB1, and one outside the region in 93 commercially available liver samples. All SNPs were in Hardy-Weinberg Equilibrium and showed linkage disequilibrium patterns consistent with those seen in the Rancho Bernardo Study (not shown). One outlier sample was removed after performing linear regression diagnostics and the reference liver sample was also not included, leaving a sample size of 91 (57% female). Because of the apparent estrogen dependency of SCARB1 variants on lipid levels, we examined primary sex effects, primary genotype effects and interactive effects between sex and SCARB1 genotype on mRNA expression.
###end p 46
###begin p 47
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 255 261 255 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 286 292 286 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lower </italic>
###xml 310 316 310 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 388 389 388 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 691 698 691 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 923 924 921 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 1415 1421 1413 1419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 1908 1914 1906 1912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 2054 2056 2052 2054 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 2087 2089 2085 2087 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 2260 2267 2258 2265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 50 55 <span type="species:ncbi:9606">human</span>
###xml 497 500 <span type="species:ncbi:9606">men</span>
###xml 505 510 <span type="species:ncbi:9606">women</span>
###xml 1049 1054 <span type="species:ncbi:9606">women</span>
###xml 1077 1080 <span type="species:ncbi:9606">men</span>
###xml 1139 1144 <span type="species:ncbi:9606">women</span>
###xml 1216 1221 <span type="species:ncbi:9606">women</span>
###xml 1451 1456 <span type="species:ncbi:9606">women</span>
###xml 2288 2293 <span type="species:ncbi:9606">women</span>
Previous studies found that estrogen treatment of human HepG2 cells results in a decrease in SR-BI and increase of SR-BII[24,27]. First, as a proxy for estrogen effects, we examined male-female differences in liver expression of SR-BI, SR-BII and overall SCARB1. We found significantly lower levels of overall SCARB1, SR-BI isoform and SR-BII isoform in female versus male livers (Figure 3). Next, we examined the effect of each of the seven SNPs on expresssion in the combined liver samples from men and women, but no significant associations were found. We then repeated this analysis, assessing SNP by sex interaction for all SNPs. We found modest evidence of interaction between sex and SCARB1 SNP rs838896 influencing expression of the SR-BI isoform (p = 0.09), which became stronger when restricting analysis to subjects </=45 years old (p = 0.04), leading us to carry out sex-stratified analyses. As shown in Figure 4, presence (+) of the rs838896 minor allele, C, was associated with significantly lower levels of SR-BI in liver tissue from women (p = 0.01) but not in men (p = 0.65). Restricting the analysis to liver tissue from women <45 years of age, the genotype association became stronger: in younger women, presence of at least one copy of the rs838896C allele conferred a 38% lower level of SR-BI (p = 0.002), a non-signfiicant 26% lower level of SR-BII (p = 0.16) and a 28% lower level of overall SCARB1(p = 0.02), compared to young women not carrying this allele. Similar, but less significant associations were seen for other SNPs on the haplotype block (rs7977729, rs838891, rs838892, rs838893, rs838895, and rs838896). It is noteworthy that rs838895, which showed the strongest association with lipids in the Rancho Bernardo Study, did not reach significance in the liver gene expression analysis (e.g. in females <45, the p values were 0.07, 0.13 and 0.54 for association with overall SCARB1, SR-BI and SR-BII expression). This may be due to differences in linkage disequilibrium between rs838895 and rs838896 in the two studies: r2 = 0.80 in Rancho Bernardo and r2 = 0.62 in the livers. No associations were found for the one SNP outside of the block (rs10846744). We then compared relative levels of each splice form (ratio to overall SCARB1 expression) in young women and found no significant differences by genotype: Carriers of the rs838896 minor allele (rs838896+) had on average 41 +/- 4% SR-BI and 3.9 +/- 0.4 % SR-BII while non-carriers (rs838896-) had average levels of 47 +/- 5% and 3.6 +/- 0.4%, respectively.
###end p 47
###begin p 48
###xml 0 56 0 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sex differences in mRNA expression in human liver tissue</bold>
###xml 171 177 163 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 214 219 <span type="species:ncbi:9606">human</span>
Sex differences in mRNA expression in human liver tissue. Shown are average DeltaDeltaCt values with standard error bars for full length SR-BI isoform, SR-BII and overall SCARB1, all relative to PPIA control in 91 human liver tissue, controlling for effects of age and post-mortem interval.
###end p 48
###begin p 49
###xml 41 48 41 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 0 64 0 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mRNA expression in human liver tissue by <italic>SCARB1 </italic>genotype and sex</bold>
###xml 199 205 191 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 19 24 <span type="species:ncbi:9606">human</span>
mRNA expression in human liver tissue by SCARB1 genotype and sex. Results shown are average DeltaDeltaCt values with standard error bars for A.) Full length SR-BI isoform; B.) SR-BII and C.) overall SCARB1, all relative to PPIA control. Rs838896+ refers to carrier of the G allele (GG and GC); Rs838896- refers to genotype CC.
###end p 49
###begin title 50
Discussion
###end title 50
###begin p 51
###xml 112 119 112 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 257 264 257 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 693 700 693 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 72 77 <span type="species:ncbi:9606">women</span>
###xml 561 566 <span type="species:ncbi:9606">women</span>
The results of our study in a community-based cohort of post-menopausal women demonstrate that polymorphisms of SCARB1 are associated with HDL cholesterol and triglyceride levels in an endogenous estrogen-dependent fashion. Specifically, variant alleles of SCARB1 in a block encompassing intron 11 to intron 12 were associated with increased triglycerides and decreased HDL cholesterol in the presence of high levels of endogenous estradiol, but the opposite was seen at lower levels of estradiol. Importantly, these effects were observed among post-menopausal women who already have low levels of estradiol, suggesting that small changes in endogenous estradiol can impact the association of SCARB1 genotype on serum lipid levels.
###end p 51
###begin p 52
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 634 636 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 1301 1303 1301 1303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 835 841 <span type="species:ncbi:9796">equine</span>
In contrast, we did not find evidence of interaction between these same genotypes and current use of oral estrogen therapy, as one might expect, nor did we find evidence of genotype by endogenous estradiol interaction for two SNPs reported to interact with oral estrogen therapy in our previous study of HDL cholesterol (data not shown). These discrepancies may be related to the marked perturbation of hepatic metabolism produced by oral estrogen therapy, including increased plasma levels of VLDL, and HDL, and reduced plasma LDL[37,38]. Oral estrogen is administered in high doses due to poor systemic bioavailability averaging 5%[39] and thus hepatocyte exposure to oral estrogen may be magnified, exceeding the physiological range. Another difference between oral and endogenous estrogen is that the former has typically involved equine estrogens (particularly during the period of sample collection for this study) whereas estradiol is the most active endogenous estrogen. Their effects on gene expression relevant to lipid metabolism may be quite different. Another possibility is that the SNPs that interacted with estrogen therapy in our previous study could reflect other differences between users and non-users of estrogen therapy, the former being younger and having lower fasting glucose[28], as well as having lower testosterone (unpublished data).
###end p 52
###begin p 53
###xml 112 119 112 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 540 547 540 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 610 612 610 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 613 615 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 616 618 616 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 619 621 619 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 357 362 <span type="species:ncbi:9606">women</span>
We further demonstrate in the current study that in liver tissues from young, adult females (but not males) the SCARB1 rs838896 minor allele from the identified haplotype block is associated with lower overall expression, driven in large part by the SR-BI isoform. Hence, increased expression of SR-BI may underlie the protective lipid profiles observed in women with both high levels of estradiol and homozygous for the rs838896 wildtype allele as observed in the Rancho Bernardo Study, and could account for underlying sex differences in SCARB1 genetic associations with lipids described in previous studies[11-15,17,18].
###end p 53
###begin p 54
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 582 589 582 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 876 878 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 922 929 922 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 1055 1057 1055 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 1124 1129 1124 1129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1350 1355 1350 1355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1465 1472 1465 1472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARBI </italic>
###xml 1711 1713 1711 1713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 2128 2135 2128 2135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 174 179 <span type="species:ncbi:9606">women</span>
###xml 209 214 <span type="species:ncbi:9606">women</span>
###xml 313 316 <span type="species:ncbi:9606">men</span>
###xml 346 351 <span type="species:ncbi:9606">human</span>
###xml 701 706 <span type="species:ncbi:9606">human</span>
###xml 774 779 <span type="species:ncbi:9606">human</span>
###xml 983 988 <span type="species:ncbi:9606">human</span>
###xml 1264 1270 <span type="species:ncbi:9796">equine</span>
###xml 1922 1927 <span type="species:ncbi:9606">human</span>
Previous studies in rodent models and human HepG2 cell lines indicate that estrogen down-regulates SR-BI and up-regulates SR-BII isoforms[24,27]. Thus, one would expect that women (specifically pre-menopausal women with higher levels of estrogen) would have lower levels of SR-BI and higher levels of SR-BII than men. Our findings in a series of human liver tissues confirm that females have significantly lower levels of hepatic SR-BI expression compared to males, but SR-BII levels were not higher; in fact levels of SR-BII were lower in females, especially among carriers of the SCARB1 rs838896 minor allele (the same genotype of HepG2 cell lines, data not shown). Although experimental results in human liver tissue may not equate with those in rodent liver or cultured human HepG2 cell lines, these discrepant findings warrant further investigation. In the study by Graf[27], antibodies specific to the 3' end of the SCARB1 protein were used to distinguish SR-BI from SR-BII in human HepG2 cell lines treated with 17 estradiol. In the study by Zhang[24], treatment of HepG2 cell lines under the same conditions as Graf et al. did not produce any changes in SR-BI or SR-BII. Only after subsequent introduction of estrogen receptor and treatment with synthetic equine estrogen did they recapitulate the increase in SR-BII expression noted by Graf et al. However, SR-BII was not measured directly, but was determined by calculating the difference between overall SCARBI and SR-BI levels. SR-BII, resulting from skipping of exon 12, is the most studied alternatively splice form, but may not be the only splice form. Additional splice forms have been described in genomic databases such as Entrez Gene Aceview[40], including one form that differs dramatically in the 3' end of the gene, missing both exons 12 and 13 and retaining a large segment of intron 11 as coding. We confirmed the expression of this splice form in human brain and liver tissues (data not shown). Thus, differences in our findings from others may relate to the method of detection of SR-BII expression and the possible existence of additional isoforms of SCARB1 not accounted for in any published analyses to date.
###end p 54
###begin p 55
###xml 92 99 92 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 205 211 205 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 230 237 230 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 680 687 680 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 766 773 766 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 106 109 <span type="species:ncbi:10116">rat</span>
###xml 224 229 <span type="species:ncbi:9606">human</span>
Recently, Zhang and colleagues proposed that estrogen regulation of alternative splicing of SCARB1 in the rat occurs via regulatory splicing factors that interact with regulatory sequences in intron 11 of SCARB1[24,41]. The human SCARB1 polymorphisms most strongly associated with estrogen-dependent splicing and lipid traits in our study are located on a haplotype block spanning intron 11 to intron 12. The coincidental location of the putative regulatory region identify by Zhang and the presence of SNPs controlling SR-BI isoform expression in our study lead us to suspect that the polymorphism underlying our observed association impacts the estrogen-dependent regulation of SCARB1 expression, perhaps of specific isoforms. Our data do not support an effect of SCARB1 SNPs on relative amounts of SR-BI or SR-BII in liver, but the possibility that other isoforms are impacted by these gene variants should be explored. Whether the rs838896 variant is the causal variant or in linkage disequilibrium with the causal variant remains to be determined in follow up functional studies using cell culture and other systems.
###end p 55
###begin p 56
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 472 478 472 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 581 588 581 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 629 636 629 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 775 783 775 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 784 786 784 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 887 889 887 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 963 970 963 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 123 128 <span type="species:ncbi:9606">women</span>
###xml 134 137 <span type="species:ncbi:9606">men</span>
###xml 247 252 <span type="species:ncbi:9606">women</span>
###xml 265 268 <span type="species:ncbi:9606">men</span>
###xml 364 369 <span type="species:ncbi:9606">women</span>
###xml 536 541 <span type="species:ncbi:9606">women</span>
###xml 560 565 <span type="species:ncbi:9606">women</span>
###xml 666 683 <span type="species:ncbi:11103">Hepatitis C virus</span>
###xml 685 688 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 803 808 <span type="species:ncbi:9606">women</span>
###xml 843 846 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 985 996 <span type="species:ncbi:11103">Hepatitis C</span>
Both HDL cholesterol and triglyceride levels are sexually dimorphic traits: levels of HDL cholesterol are 20-25% higher in women than men and these differences persist over time; triglyceride levels, on the other hand, start out slightly lower in women compared to men in young adulthood, but around the time of menopause, triglyceride levels rise dramatically in women[42]. We propose that this rise in triglycerides may be attributable in part to estrogen regulation of SCARB1, and that the protection afforded by estrogen in younger women may be limited to women with a certain SCARB1 genotype. It is interesting to note that SCARB1 is also a co-receptor for the Hepatitis C virus (HCV) and that increased expression of both SR-BI and SR-BII isoforms increase infectivity in vitro[43]. Additionally, women generally have better outcomes of HCV infection, perhaps related to estrogen [44], leading us to speculate on the role of estrogen-mediated expression of SCARB1 in outcomes of Hepatitis C infection.
###end p 56
###begin p 57
###xml 44 51 44 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 577 579 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 580 582 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 730 732 730 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 134 139 <span type="species:ncbi:9606">women</span>
###xml 670 675 <span type="species:ncbi:9606">women</span>
###xml 803 808 <span type="species:ncbi:9606">women</span>
Our study of the phenotypic consequences of SCARB1 variation was carried out in a community-based sample of post-menopausal Caucasian women who were not selected based on any disease phenotype. The samples and data were collected before the widespread use of lipid lowering therapy, thus reducing confounding by treatment. Yet, there are some caveats of our study, including that estradiol assays were measured only once. Although single measurements of most hormones reliably characterize average levels over a two to three year period, estradiol levels are less reproducible[45,46]. However, estradiol was measured in morning fasting samples, and among postmenopausal women estradiol does not show significant diurnal variation[47]. Moreover, it should be noted that this was an elderly population of women, with relatively low levels of estradiol; we might expect estrogen effects to be more pronounced in a younger population. As with most large scale SNP association studies, ours is also prone to false positive associations, the result of multiple testing. Replication of the observed associations in other study populations is warranted.
###end p 57
###begin title 58
Conclusions
###end title 58
###begin p 59
###xml 61 68 61 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 77 85 77 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo </italic>
###xml 385 392 385 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 88 93 <span type="species:ncbi:9606">human</span>
###xml 332 337 <span type="species:ncbi:9606">human</span>
In summary, our work has detected sex-specific expression of SCARB1 isoforms in vivo in human liver tissue and identified polymorphisms in intron 11 of the gene that modify this effect. We further found these same genetic variants to influence triglyceride and HDL cholesterol levels in an endogenous estrogen-dependent manner in a human population study. Thus, estrogen regulation of SCARB1 may contribute to the observed sexual dimorphism of lipid levels and highlights the importance of considering sex-dependent effects of gene variants on serum lipid levels.
###end p 59
###begin title 60
Competing interests
###end title 60
###begin p 61
The authors declare that they have no competing interests.
###end p 61
###begin title 62
Authors' contributions
###end title 62
###begin p 63
OCF contributed to the conception and design, oversaw the molecular genetic studies, and contributed to drafting of the manuscript; MN carried out the molecular genetic analysis; SS carried out the genetic association analysis; JG, GG and EBC participated in interpretation of data and manuscript revisions; JJM conceived and designed the study, drafted the manuscript and oversaw all genetic analyses. All authors have read and approved the final manuscript.
###end p 63
###begin title 64
Pre-publication history
###end title 64
###begin p 65
The pre-publication history for this paper can be accessed here:
###end p 65
###begin p 66

###end p 66
###begin title 67
Supplementary Material
###end title 67
###begin title 68
Additional file 1
###end title 68
###begin p 69
###xml 0 79 0 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S1. Validation curves of the &#916;&#916; real-time gene expression assays</bold>
###xml 110 116 102 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1</italic>
###xml 281 288 269 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SCARB1 </italic>
###xml 293 297 281 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
Figure S1. Validation curves of the DeltaDelta real-time gene expression assays. Shown are curves for overall SCARB1, SR-BI and SR-BII versus endogenous control (PPIA). Relative efficiency plots were formed by plotting the log input amount (ng of total RNA) versus the DeltaCt (Ct SCARB1 - Ct PPIA), for example. The slopes are <0.1 which indicates the validation of the DeltaDeltaCt calculation relative to the reference controls in the range between 1-100 ng RNA.
###end p 69
###begin p 70
Click here for file
###end p 70
###begin title 71
Acknowledgements
###end title 71
###begin p 72
###xml 497 502 <span type="species:ncbi:9606">Child</span>
###xml 514 519 <span type="species:ncbi:9606">Human</span>
We would like to thank Sonal Patel and Colton Linnertz for their technical assistance in the laboratory. This study was supported in part by grant RO1 HL085191-01 from the National Heart, Lung and Blood Institute (P.I. McCarthy), grant P60 MD00220, grant DK31801 from the National Institute of Diabetes and Digestive and Kidney Diseases (P.I. Barrett-Connor) and grant AG07181 (P.I. Barrett-Connor) from the National Institute on Aging. Liver tissues were purchased from the National Institute of Child Health and Human Development Brain and Tissue Bank for Developmental Disorders under contracts N01-HD-4-3368 and NO1-HD-4-3383.
###end p 72
###begin article-title 73
Identification of scavenger receptor SR-BI as a high density lipoprotein receptor
###end article-title 73
###begin article-title 74
###xml 29 34 <span type="species:ncbi:9606">human</span>
Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes
###end article-title 74
###begin article-title 75
Cellular and physiological roles of SR-BI, a lipoprotein receptor which mediates selective lipid uptake
###end article-title 75
###begin article-title 76
###xml 63 68 <span type="species:ncbi:9606">human</span>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
Physiological importance of SR-BI in the in vivo metabolism of human HDL and LDL in male and female mice
###end article-title 76
###begin article-title 77
Scavenger receptor BI facilitates the metabolism of VLDL lipoproteins in vivo
###end article-title 77
###begin article-title 78
###xml 50 54 <span type="species:ncbi:10090">mice</span>
The hepatic uptake of VLDL in lrp-ldlr-/-vldlr-/- mice is regulated by LPL activity and involves proteoglycans and SR-BI
###end article-title 78
###begin article-title 79
###xml 70 73 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains
###end article-title 79
###begin article-title 80
###xml 0 17 <span type="species:ncbi:11103">Hepatitis C virus</span>
Hepatitis C virus cell entry: role of lipoproteins and cellular receptors
###end article-title 80
###begin article-title 81
High density lipoprotein uptake by scavenger receptor SR-BII
###end article-title 81
###begin article-title 82
SR-BII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells
###end article-title 82
###begin article-title 83
Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population
###end article-title 83
###begin article-title 84
Polymorphisms at the SRBI locus are associated with lipoprotein levels in subjects with heterozygous familial hypercholesterolemia
###end article-title 84
###begin article-title 85
###xml 84 89 <span type="species:ncbi:9606">women</span>
Association of genetic variants in the HDL receptor, SR-B1, with abnormal lipids in women with coronary artery disease
###end article-title 85
###begin article-title 86
Polymorphisms of the HDL receptor gene associated with HDL cholesterol levels in diabetic kindred from three populations
###end article-title 86
###begin article-title 87
Association between HaeIII polymorphism of scavenger receptor class B type I gene and plasma HDL-cholesterol concentration
###end article-title 87
###begin article-title 88
Association between a novel 11-base pair deletion mutation in the promoter region of the scavenger receptor class B type I gene and plasma HDL cholesterol levels in Taiwanese Chinese
###end article-title 88
###begin article-title 89
Population-based study of SR-BI genetic variation and lipid profile
###end article-title 89
###begin article-title 90
###xml 105 110 <span type="species:ncbi:9606">women</span>
Variants in scavenger receptor class B type I gene are associated with HDL cholesterol levels in younger women
###end article-title 90
###begin article-title 91
###xml 57 62 <span type="species:ncbi:9606">women</span>
Cholesterol, lipoproteins, and coronary heart disease in women
###end article-title 91
###begin article-title 92
Estrogen regulation of the scavenger receptor class B gene: Anti-atherogenic or steroidogenic, is there a priority?
###end article-title 92
###begin article-title 93
###xml 130 133 <span type="species:ncbi:10116">rat</span>
Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat
###end article-title 93
###begin article-title 94
###xml 119 122 <span type="species:ncbi:10116">rat</span>
In vivo regulation of scavenger receptor BI and the selective uptake of high density lipoprotein cholesteryl esters in rat liver parenchymal and Kupffer cells
###end article-title 94
###begin article-title 95
###xml 62 65 <span type="species:ncbi:10116">rat</span>
Effect of estrogen on scavenger receptor BI expression in the rat
###end article-title 95
###begin article-title 96
Regulation of alternative splicing of liver scavenger receptor class B gene by estrogen and the involved regulatory splicing factors
###end article-title 96
###begin article-title 97
###xml 86 89 <span type="species:ncbi:10116">rat</span>
Scavenger receptor BI mediates the selective uptake of oxidized cholesterol esters by rat liver
###end article-title 97
###begin article-title 98
###xml 44 47 <span type="species:ncbi:10116">rat</span>
Catabolism of HDL1 cholesteryl ester in the rat. Effect of ethinyl estradiol treatment
###end article-title 98
###begin article-title 99
###xml 76 79 <span type="species:ncbi:10116">rat</span>
17beta-Estradiol promotes the up-regulation of SR-BII in HepG2 cells and in rat livers
###end article-title 99
###begin article-title 100
Modification of the effects of estrogen therapy on HDL cholesterol levels by polymorphisms of the HDL-C receptor, SR-BI: the Rancho Bernardo Study
###end article-title 100
###begin article-title 101
Differences between respondents and non-respondents in a population-based cardiovascular disease study
###end article-title 101
###begin article-title 102
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
###end article-title 102
###begin article-title 103
A simple method for the assay of eight steroids in small volumes of plasma
###end article-title 103
###begin article-title 104
Haploview: analysis and visualization of LD and haplotype maps
###end article-title 104
###begin article-title 105
###xml 62 67 <span type="species:ncbi:10090">mouse</span>
Reference gene selection for real-time RT-PCR in regenerating mouse livers
###end article-title 105
###begin article-title 106
Allelic discrimination using fluorogenic probes and the 5' nuclease assay
###end article-title 106
###begin article-title 107
R package ggplot2: An implementation of the Grammar of Graphics
###end article-title 107
###begin article-title 108
###xml 58 64 <span type="species:ncbi:9796">equine</span>
###xml 215 220 <span type="species:ncbi:9606">women</span>
A comparison of the short-term effects of oral conjugated equine estrogens versus transdermal estradiol on C-reactive protein, other serum markers of inflammation, and other hepatic proteins in naturally menopausal women
###end article-title 108
###begin article-title 109
Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins
###end article-title 109
###begin article-title 110
Bioavailability of orally administered sex steroids used in oral contraception and hormone replacement therapy
###end article-title 110
###begin article-title 111
AceView: a comprehensive cDNA-supported gene and transcripts annotation
###end article-title 111
###begin article-title 112
Characterization of regulatory intronic and exonic sequences involved in alternative splicing of scavenger receptor class B gene
###end article-title 112
###begin article-title 113
Trends in serum lipids and lipoproteins of adults, 1960-2002
###end article-title 113
###begin article-title 114
###xml 57 74 <span type="species:ncbi:11103">hepatitis C virus</span>
Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity
###end article-title 114
###begin article-title 115
###xml 8 19 <span type="species:ncbi:11103">hepatitis C</span>
Chronic hepatitis C and fibrosis: evidences for possible estrogen benefits
###end article-title 115
###begin article-title 116
###xml 59 64 <span type="species:ncbi:9606">women</span>
Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period
###end article-title 116
###begin article-title 117
###xml 66 71 <span type="species:ncbi:9606">women</span>
Reliability of serum hormones in premenopausal and postmenopausal women over a one-year period
###end article-title 117
###begin article-title 118
###xml 60 65 <span type="species:ncbi:9606">women</span>
A circadian rhythm of serum follicle-stimulating hormone in women
###end article-title 118

